Anti-CLEC12A antibody therapy for multiple sclerosis and neuroinflammatory diseases
Novel therapeutic approach targeting CLEC12A-mediated myeloid cell trafficking across the blood-brain barrier to treat multiple sclerosis. Blocking antibodies to CLEC12A reduce disease severity, delay onset, and decrease...